South Korea

Resilience System

Main menu


ANALYSIS: Five reasons why COVID herd immunity is probably impossible

https://www.nature.com/articles/d41586-021-00728-2

As COVID-19 vaccination rates pick up around the world, people have reasonably begun to ask: how much longer will this pandemic last? It’s an issue surrounded with uncertainties. But the once-popular idea that enough people will eventually gain immunity to SARS-CoV-2 to block most transmission — a ‘herd-immunity threshold’ — is starting to look unlikely.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

ANALYSIS: Post-immunization casesare very rare and but also very expected.

Surging COVID-19 cases in Europe, Brazil are a warning for US

Substantial surges in new coronavirus cases and hospitalizations in Europe and Brazil offer a worrying preview of what the United States faces in the coming weeks and months as the plummeting number of cases here begins to level off.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Biden hopes to double the 100 milliion coronavirus shots given as of today

OPINION: Suggestions for countering disinformation about COVID vaccines and masks

ANALYSIS: The first big study of COVID reinfection

Cases of children with long haul symptoms are rare but growing.

Study finds children have surprisingly high rate of COVID-19 antibodies

A study out of Northern Virginia shows children had a surprisingly high rate of COVID-19 antibodies.

Inova Health System partnered with Virginia Department of Health and George Mason University to look at the rate of COVID-19 in children. It was done in the Fall.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

CDC backs distance of three feet between students, which may help schools open

NEW YORK (AP) — The Centers for Disease Control and Prevention relaxed its social distancing guidelines for schools Friday, saying students can now sit 3 feet apart in classrooms.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

OVERVIEW: COVID-19 International briefs

(Reuters) - Nearly a dozen countries resumed use of AstraZeneca’s COVID-19 shots on Friday as EU and British regulators said its benefits outweighed any risks. Reports of rare instances of blood clotting had temporarily halted inoculations.

Problem, Solution, SitRep, or ?: 

Europe resumes vaccinations after clearing AstraZeneca vaccine

Europe's pause of AstraZeneca prompts doubts in Africa

Not enough vaccine in Europe to stop third wave, warns German Health Minister

Low-dose aspirin is useful against Covid --researchers

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

EU's drug investigators back AstraZeneca vaccine as safe and effective

Pages

Subscribe to South Korea RSS
howdy folks
Page loaded in 1.124 seconds.